Locally Advanced Malignant Solid Neoplasm Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-22
Mar 22, 2022
N
Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Dabrafenib Mesylate
  • +2 more
  • Los Angeles, California
  • +15 more
2022-03-25
Mar 25, 2022
N
Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Bethesda, Maryland
    National Cancer Institute Developmental Therapeutics Clinic
2022-03-17
Mar 17, 2022
F
Suspended
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +33 more
  • Communication Intervention
  • +2 more
  • New York, New York
  • +1 more
2022-03-02
Mar 2, 2022
M
Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
2022-02-25
Feb 25, 2022
N
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Orange, California
  • +28 more
2022-03-01
Mar 1, 2022
O
Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +18 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
2022-02-11
Feb 11, 2022
S
Withdrawn
  • Advanced Malignant Neoplasm
  • +10 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-02-15
Feb 15, 2022
M
Active, not recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-18
Jan 18, 2022
M
Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Larotrectinib Sulfate
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-21
Dec 21, 2021
M
Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +3 more
  • Electroencephalography
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-12
Oct 12, 2021
M
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-12
Oct 12, 2021
U
Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
  • VLP-encapsulated TLR9 Agonist CMP-001
  • Scottsdale, Arizona
  • +3 more
2021-10-14
Oct 14, 2021
N
Withdrawn
  • Aggressive Non-Hodgkin Lymphoma
  • +3 more
  • p97 Inhibitor CB-5339 Tosylate
  • Bethesda, Maryland
  • +1 more
2021-08-27
Aug 27, 2021
U
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Support Group Therapy
  • +3 more
  • San Francisco, California
    University of California, San Francisco
2021-08-20
Aug 20, 2021
M
Not yet recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-08-10
Aug 10, 2021
M
Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Communication Intervention
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-03
May 3, 2021
R
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +10 more
  • San Francisco, California
    University of California, San Francisco
2021-04-05
Apr 5, 2021
M
Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +28 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-02-23
Feb 23, 2021
M
Recruiting
  • ALK Positive
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-02-14
Feb 14, 2020